Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human SAA1 Antibodies:
anti-Mouse (Murine) SAA1 Antibodies:
anti-Rat (Rattus) SAA1 Antibodies:
Go to our pre-filtered search.
Human Monoclonal SAA1 Primary Antibody for IA, IHC (fro) - ABIN2191976
Wilkins, Gallimore, Tennent, Hawkins, Limburg, van Rijswijk, Moore, Pepys: Rapid automated enzyme immunoassay of serum amyloid A. in Clinical chemistry 1994
Show all 2 Pubmed References
Cow (Bovine) Polyclonal SAA1 Primary Antibody for WB - ABIN2783217
Zeng, Du, Zhou, Huang: Role of SelS in lipopolysaccharide-induced inflammatory response in hepatoma HepG2 cells. in Archives of biochemistry and biophysics 2008
Serum amyloid A forms stable nanoparticles with phospholipids.
findings show that high-density lipoprotein binding blocks fibril formation from soluble SAA1 protein, whereas internalization into mononuclear phagocytes leads to formation of amyloid; SAA1 aggregation in the cell model disturbs the integrity of vesicular membranes and leads to lysosomal leakage and apoptotic death
SAA represents a valid biomarker for influenza disease detection in all tested mouse strains but its prognostic value is limited to BALB/c mice infected with influenza A(H1N1)pdm09 virus.
These findings suggest that A-SAA is functionally linked to pulmonary inflammation in this O3 exposure model and that A-SAA could be an important systemic signal of O3 exposure to the CNS.-
study reports that truncated SAA1 proteins lacking N- and C-terminal sequences exhibit reduced proinflammatory activity and strongly suppress LPS (show TLR4 Antibodies)-induced expression of IL-1beta (show IL1B Antibodies), IL-6 (show IL6 Antibodies), and TNF-alpha (show TNF Antibodies) in macrophages
though the clearance rate of SAA was reduced in the absence of the HDL (show HSD11B1 Antibodies) receptor, scavenger receptor class B type I (SR-BI), it remained significantly faster compared with that of apoA-I (show APOA1 Antibodies) and apoA-II (show APOA2 Antibodies), indicating a relatively minor role of SR-BI (show SCARB1 Antibodies) in SAA's rapid clearance. These studies enhance our understanding of SAA metabolism and SAA's effects on AP-HDL (show HSD11B1 Antibodies) composition and catabolism.
SAA and TLR4 (show TLR4 Antibodies) have a role in skin inflammation
SAA is a potential new uremic toxin involved in uremia-related atherosclerosis through interaction with RAGE (show AGER Antibodies).
Data indicate that SAA1 overexpressing mice (TG) show significant deficits in social behaviors, including impaired social recognition and reduced social interaction. Study detected exogenous SAA1 expression in the brain of TG mice, implying that liver-derived SAA1 migrates to the brain. Results show an increase in the accumulation of the 87kDa form of Abeta (show APP Antibodies) in TG mice compared to wild type mice.
Mass spectrometry analysis of peptides derived from chemically crosslinked HDL (show HSD11B1 Antibodies)-SAA particles detected multiple crosslinks between apoA1 (show APOA1 Antibodies) and SAA, indicating close proximity (within 25 A) of these two proteins on the HDL (show HSD11B1 Antibodies) surface, providing a molecular and structural mechanism for the simultaneous binding of heparin to apoA1 (show APOA1 Antibodies) and SAA.
we show that astrocytoma patients have increased levels of serum SAA and SAA1 is expressed and secreted in glioblastoma, and its co-expression with tumor-related genes supports its involvement in glioblastoma angiogenesis and progression.
These results suggested that the C-terminal truncation of human SAA accelerates amyloid fibril formation.
SAA1 can be a potential mediator for UV-induced MMP-1 (show MMP1 Antibodies) expression in human skin.
Data suggest that serum amyloid A (SAA) immunoreactivity in tumor-associated macrophage (TAM) is associated with worse recurrence-free survival, and is perhaps a therapeutic target for breast cancer.
Findings indicate that in Lyme disease patients, circulating CRP and SAA (Serum Amyloid A) levels are highest when the concentration of spirochetes is greatest in skin and/or blood and that levels decline after the dissemination of the organism to extracutaneous sites in subsequent stages of infection.
The Serum amyloid A (SAA)/formyl peptide receptor-like 1 (FPRL1 (show FPR2 Antibodies)) contributed to pathogenesis of psoriasis by promoting keratinocyte proliferation and inflammation, thus providing a potential therapeutic target for disease therapy.
High SAA expression is associated with lung cancer.
SAA, PROZ (show PROZ Antibodies), and C4BPB (show C4BPB Antibodies) may serve as new potential biomarkers for TB
Novel truncated form of serum amyloid A is elevated in the plasma of Kawasaki disease (KD) when compared with Febrile control subjects. Future studies will evaluate its relevance as a diagnostic biomarker and its potential role in the pathophysiology of KD.
SR-A1 suppresses lung cancer metastasis by downregulating SAA1 production in tumor-associated macrophages (TAM (show CCNA1 Antibodies)).
polymorphisms in the SAA2 gene are associated with milk production traits in Chinese Holstein cows
endometritis gives rise to a systemic acute phase response and an up-regulated endometrial gene expression of SAA and several pro-and anti-inflammatory cytokines
The levels of surfactant protein D and serum amyloid A protein in normal horses and those with bacterial pneumonia are reported.
This gene encodes a member of the serum amyloid A family of apolipoproteins. The encoded protein is a major acute phase protein that is highly expressed in response to inflammation and tissue injury. This protein also plays an important role in HDL metabolism and cholesterol homeostasis. High levels of this protein are associated with chronic inflammatory diseases including atherosclerosis, rheumatoid arthritis, Alzheimer's disease and Crohn's disease. This protein may also be a potential biomarker for certain tumors. Alternate splicing results in multiple transcript variants that encode the same protein. A pseudogene of this gene is found on chromosome 11.
serum amyloid A protein
, serum amyloid A-1 protein
, tumor protein p53 inducible protein 4
, serum amyloid A1
, serum amyloid A
, serum amyloid a protein
, Hermansky-Pudlak syndrome 5
, serum amyloid A 2